Miriam Canavese
- Hematology top 5%
- Multiple Myeloma Research and Treatments 6
- Oncology top 10%
- Peptidase Inhibition and Analysis 5
- Cytokine Signaling Pathways and Interactions 2
-
- Histone Deacetylase Inhibitors Research 3
- Angiogenesis and VEGF in Cancer 3
-
- Psoriasis: Treatment and Pathogenesis 4
-
- Malaria Research and Control 3
-
- Virus-based gene therapy research 2
- Co-authors
- Noopur RajeLoredana SantoFiorella AltrudaKenneth C. AndersonTeru HideshimaMatthew JarpeWalter C. OgierHomare Eda
- Cited by
- HematologyOncologyMolecular Biology
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Miriam Canavese
20 papers receiving 904 citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Hematology 168
- Oncology 398
- Molecular Biology 674
- Immunology 125
- Cancer Research 62
Countries citing papers authored by Miriam Canavese
This map shows the geographic impact of Miriam Canavese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam Canavese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam Canavese more than expected).
Fields of papers citing papers by Miriam Canavese
This network shows the impact of papers produced by Miriam Canavese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam Canavese. The network helps show where Miriam Canavese may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Miriam Canavese, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 4 | |
| 2 | 2019 | 0 | |
| 3 | 2016 | 34 | |
| 4 | 2016 | 13 | |
| 5 | 2015 | 9 | |
| 6 | 2015 | 7 | |
| 7 | 2015 | 2 | |
| 8 | 2014 | 72 | |
| 9 | 2014 | 22 | |
| 10 | 2012 | 130 | |
| 11 | Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myelomabreakdown → | 2012 | 488 |
| 12 | 2011 | 2 | |
| 13 | 2011 | 1 | |
| 14 | 2011 | 2 | |
| 15 | 2011 | 4 | |
| 16 | 2011 | 3 | |
| 17 | 2011 | 1 | |
| 18 | 2011 | 2 | |
| 19 | 2010 | 88 | |
| 20 | 2010 | 22 |
About Miriam Canavese
Miriam Canavese is a scholar working on Hematology, Oncology and Biological Psychiatry, having authored 21 papers that have together received 923 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (6 papers), Peptidase Inhibition and Analysis (5 papers), Psoriasis: Treatment and Pathogenesis (4 papers), Histone Deacetylase Inhibitors Research (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Malaria Research and Control (3 papers), Virus-based gene therapy research (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Hematology (168 citations), Oncology (398 citations) and Molecular Biology (674 citations). Miriam Canavese has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Noopur Raje, Loredana Santo, Fiorella Altruda, Loredana Santo, Kenneth C. Anderson, Teru Hideshima, Matthew Jarpe, Walter C. Ogier, Homare Eda and Andrew L. Kung. Their work appears in journals such as Blood, PLoS ONE and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.